{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:16:15Z","timestamp":1707524175896},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,1]]},"DOI":"10.7759\/cureus.13633","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T15:02:29Z","timestamp":1614610949000},"source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulants Used in Cardiac Catheterization of Patients With Chronic Lymphocytic Leukemia: A Case Report and Overview"],"prefix":"10.7759","author":[{"given":"Anton","family":"Mararenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Alshami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"AlAzzawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapnil V","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S256993","article-title":"Suppression of CXCL-1 could restore necroptotic pathway in chronic lymphocytic leukemia","volume":"13","author":"Xu Z","year":"2020","unstructured":"Xu Z, Sun Y, Wei Z, Jiang J, Xu J, Liu P. Suppression of CXCL-1 could restore necroptotic pathway in chronic lymphocytic leukemia. Onco Targets Ther. 2020, 13:6917-6925. 10.2147\/OTT.S256993","journal-title":"Onco Targets Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2014.03.002","article-title":"The quality of antiplatelet and anticoagulant medication administration among ST-segment elevation myocardial infarction patients transferred for primary percutaneous coronary intervention","volume":"167","author":"Wang TY","year":"2014","unstructured":"Wang TY, Magid DJ, Ting HH, Li S, Alexander KP, Roe MT, Peterson ED. The quality of antiplatelet and anticoagulant medication administration among ST-segment elevation myocardial infarction patients transferred for primary percutaneous coronary intervention. Am Heart J. 2014, 167:833-839. 10.1016\/j.ahj.2014.03.002","journal-title":"Am Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2006.00734.x","article-title":"Successful percutaneous coronary intervention using bivalirudin in a patient with chronic lymphocytic leukemia and thrombocytopenia","volume":"77","author":"Krolick MA","year":"2006","unstructured":"Krolick MA. Successful percutaneous coronary intervention using bivalirudin in a patient with chronic lymphocytic leukemia and thrombocytopenia. Eur J Haematol. 2006, 77:355-357. 10.1111\/j.1600-0609.2006.00734.x","journal-title":"Eur J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182742cf6","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O\u2019Gara PT","year":"2013","unstructured":"O\u2019Gara PT, Kushner FG, Ascheim DD, et al.. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013, 127:362-425. 10.1161\/CIR.0b013e3182742cf6","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)","volume":"33","author":"Steg PG","year":"2012","unstructured":"Steg PG, James SK, Atar D, et al.. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J. 2012, 33:2569-2619. 10.1093\/eurheartj\/ehs215","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.28432","article-title":"Percutaneous coronary intervention and in-hospital outcomes in patients with leukemia: a nationwide analysis","volume":"96","author":"Potts J","year":"2020","unstructured":"Potts J, Mohamed MO, Lopez Mattei JC, et al.. Percutaneous coronary intervention and in-hospital outcomes in patients with leukemia: a nationwide analysis. Catheter Cardiovasc Interv. 2020, 96:53-63. 10.1002\/ccd.28432","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(20)30398-4","article-title":"Thrombosis in hematological malignancies: mechanisms and implications","volume":"191","author":"Horowitz NA","year":"2020","unstructured":"Horowitz NA, Brenner B. Thrombosis in hematological malignancies: mechanisms and implications. Thromb Res. 2020, 191:58-62. 10.1016\/S0049-3848(20)30398-4","journal-title":"Thromb Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.13.joc60034","article-title":"Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial","volume":"295","author":"Kastrati A","year":"2006","unstructured":"Kastrati A, Mehilli J, Neumann FJ, et al.. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA. 2006, 295:1531-1538. 10.1001\/jama.295.13.joc60034","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.827162","article-title":"Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice","volume":"119","author":"Wang TY","year":"2009","unstructured":"Wang TY, Ou FS, Roe MT, Harrington RA, Ohman EM, Gibler WB, Peterson ED. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice. Circulation. 2009, 119:2454-2462. 10.1161\/CIRCULATIONAHA.108.827162","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052711","article-title":"Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention","volume":"355","author":"Montalescot G","year":"2006","unstructured":"Montalescot G, White HD, Gallo R, et al.. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med. 2006, 355:1006-1017. 10.1056\/NEJMoa052711","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.1.45","article-title":"Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial","volume":"292","author":"Ferguson JJ","year":"2004","unstructured":"Ferguson JJ, Califf RM, Antman EM, et al.. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA. 2004, 292:45-54. 10.1001\/jama.292.1.45","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.22.2423","article-title":"Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials","volume":"167","author":"Dumaine R","year":"2007","unstructured":"Dumaine R, Borentain M, Bertel O, et al.. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials. Arch Intern Med. 2007, 167:2423-2430. 10.1001\/archinte.167.22.2423","journal-title":"Arch Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.07.042","article-title":"Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial","volume":"50","author":"Mehta SR","year":"2007","unstructured":"Mehta SR, Granger CB, Eikelboom JW, et al.. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J Am Coll Cardiol. 2007, 50:1742-1751. 10.1016\/j.jacc.2007.07.042","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199509213331204","article-title":"Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina","volume":"333","author":"Bittl JA","year":"1995","unstructured":"Bittl JA, Strony J, Brinker JA, et al.. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. N Engl J Med. 1995, 333:764-769. 10.1056\/NEJM199509213331204","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802944","article-title":"Bivalirudin versus unfractionated heparin during percutaneous coronary intervention","volume":"359","author":"Kastrati A","year":"2008","unstructured":"Kastrati A, Neumann FJ, Mehilli J, et al.. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med. 2008, 359:688-696. 10.1056\/NEJMoa0802944","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone GW","year":"2008","unstructured":"Stone GW, Witzenbichler B, Guagliumi G, et al.. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008, 358:2218-2230. 10.1056\/NEJMoa0708191","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.05.76","article-title":"Bivalirudin versus heparin in percutaneous coronary intervention\u2014a systematic review and meta-analysis of randomized trials stratified by adjunctive glycoprotein IIb\/IIIa strategy","volume":"10","author":"Narayanan M","year":"2018","unstructured":"Narayanan M, Anugula D, Gujjula NR, et al.. Bivalirudin versus heparin in percutaneous coronary intervention\u2014a systematic review and meta-analysis of randomized trials stratified by adjunctive glycoprotein IIb\/IIIa strategy. J Thorac Dis. 2018, 10:3341-3360. 10.21037\/jtd.2018.05.76","journal-title":"J Thorac Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.s5699","article-title":"Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"5","author":"Norgard NB","year":"2009","unstructured":"Norgard NB, Abu-Fadel M. Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Vasc Health Risk Manag. 2009, 5:873-882. 10.2147\/vhrm.s5699","journal-title":"Vasc Health Risk Manag"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/50945-anticoagulants-used-in-cardiac-catheterization-of-patients-with-chronic-lymphocytic-leukemia-a-case-report-and-overview","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:18Z","timestamp":1707507018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/50945-anticoagulants-used-in-cardiac-catheterization-of-patients-with-chronic-lymphocytic-leukemia-a-case-report-and-overview"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.13633","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}